越早,越小,更适合natalizumab-associated PML: MRI警惕真理?

从髓鞘(MYDREAM) (R.P.-B紊乱研究团队。S.B.),列日;神经病学(R.P.-B。首页,S.B.,G.M.), University and C.H.U. of Liège, Liège, Belgium; Department of Neurology (O.O., P.V.), Salengro Hospital, Université de Lille Nord de France, CHRU Lille; Service de Neurologie (C.S.), Cliniques Universitaires Saint-Luc, UC Louvain, Brussels; MYelin Disorders REseArch teaM (MYDREAM) (M.V.), Brussels; and Clinical Neuroimmunology Unit (M.V.), Department of Neurology, University Hospital Erasme, Brussels, Belgium.

从髓鞘(MYDREAM) (R.P.-B紊乱研究团队。S.B.),列日;神经病学(R.P.-B。首页,S.B.,G.M.), University and C.H.U. of Liège, Liège, Belgium; Department of Neurology (O.O., P.V.), Salengro Hospital, Université de Lille Nord de France, CHRU Lille; Service de Neurologie (C.S.), Cliniques Universitaires Saint-Luc, UC Louvain, Brussels; MYelin Disorders REseArch teaM (MYDREAM) (M.V.), Brussels; and Clinical Neuroimmunology Unit (M.V.), Department of Neurology, University Hospital Erasme, Brussels, Belgium.

从髓鞘(MYDREAM) (R.P.-B紊乱研究团队。S.B.),列日;神经病学(R.P.-B。首页,S.B.,G.M.), University and C.H.U. of Liège, Liège, Belgium; Department of Neurology (O.O., P.V.), Salengro Hospital, Université de Lille Nord de France, CHRU Lille; Service de Neurologie (C.S.), Cliniques Universitaires Saint-Luc, UC Louvain, Brussels; MYelin Disorders REseArch teaM (MYDREAM) (M.V.), Brussels; and Clinical Neuroimmunology Unit (M.V.), Department of Neurology, University Hospital Erasme, Brussels, Belgium.

从髓鞘(MYDREAM) (R.P.-B紊乱研究团队。S.B.),列日;神经病学(R.P.-B。首页,S.B.,G.M.), University and C.H.U. of Liège, Liège, Belgium; Department of Neurology (O.O., P.V.), Salengro Hospital, Université de Lille Nord de France, CHRU Lille; Service de Neurologie (C.S.), Cliniques Universitaires Saint-Luc, UC Louvain, Brussels; MYelin Disorders REseArch teaM (MYDREAM) (M.V.), Brussels; and Clinical Neuroimmunology Unit (M.V.), Department of Neurology, University Hospital Erasme, Brussels, Belgium.

从髓鞘(MYDREAM) (R.P.-B紊乱研究团队。S.B.),列日;神经病学(R.P.-B。首页,S.B.,G.M.), University and C.H.U. of Liège, Liège, Belgium; Department of Neurology (O.O., P.V.), Salengro Hospital, Université de Lille Nord de France, CHRU Lille; Service de Neurologie (C.S.), Cliniques Universitaires Saint-Luc, UC Louvain, Brussels; MYelin Disorders REseArch teaM (MYDREAM) (M.V.), Brussels; and Clinical Neuroimmunology Unit (M.V.), Department of Neurology, University Hospital Erasme, Brussels, Belgium.

从髓鞘(MYDREAM) (R.P.-B紊乱研究团队。S.B.),列日;神经病学(R.P.-B。首页,S.B.,G.M.), University and C.H.U. of Liège, Liège, Belgium; Department of Neurology (O.O., P.V.), Salengro Hospital, Université de Lille Nord de France, CHRU Lille; Service de Neurologie (C.S.), Cliniques Universitaires Saint-Luc, UC Louvain, Brussels; MYelin Disorders REseArch teaM (MYDREAM) (M.V.), Brussels; and Clinical Neuroimmunology Unit (M.V.), Department of Neurology, University Hospital Erasme, Brussels, Belgium.

从髓鞘(MYDREAM) (R.P.-B紊乱研究团队。S.B.),列日;神经病学(R.P.-B。首页,S.B.,G.M.), University and C.H.U. of Liège, Liège, Belgium; Department of Neurology (O.O., P.V.), Salengro Hospital, Université de Lille Nord de France, CHRU Lille; Service de Neurologie (C.S.), Cliniques Universitaires Saint-Luc, UC Louvain, Brussels; MYelin Disorders REseArch teaM (MYDREAM) (M.V.), Brussels; and Clinical Neuroimmunology Unit (M.V.), Department of Neurology, University Hospital Erasme, Brussels, Belgium.